M S Hofman

Summary

Affiliation: Peter MacCallum Cancer Centre
Country: Australia

Publications

  1. doi request reprint Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CT
    Roderick J Clifton-Bligh
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia
    J Clin Endocrinol Metab 98:687-94. 2013
  2. doi request reprint High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
    Michael S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia
    J Med Imaging Radiat Oncol 56:40-7. 2012
  3. doi request reprint Imaging in follicular NHL
    M S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    Best Pract Res Clin Haematol 24:165-77. 2011
  4. doi request reprint 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy
    Michael S Hofman
    Molecular Imaging, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    J Nucl Med 52:1513-9. 2011
  5. pmc White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
    Michael S Hofman
    Center for Cancer Imaging, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, VIC 3002 Australia
    EJNMMI Res 1:2. 2011
  6. doi request reprint The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable
    T W Barber
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia
    Eur J Surg Oncol 38:64-71. 2012

Collaborators

Detail Information

Publications6

  1. doi request reprint Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CT
    Roderick J Clifton-Bligh
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia
    J Clin Endocrinol Metab 98:687-94. 2013
    ..Serum phosphate should be measured routinely in patients with unexplained muscle weakness, bone pain, or stress fractures to allow earlier diagnosis of TIO...
  2. doi request reprint High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
    Michael S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia
    J Med Imaging Radiat Oncol 56:40-7. 2012
    ..This study assesses the management impact of incremental diagnostic information obtained from this technique compared with conventional staging...
  3. doi request reprint Imaging in follicular NHL
    M S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    Best Pract Res Clin Haematol 24:165-77. 2011
    ..Molecular imaging is likely to play an increasing role in selection of patients for specific treatments and in prognostic stratification...
  4. doi request reprint 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy
    Michael S Hofman
    Molecular Imaging, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    J Nucl Med 52:1513-9. 2011
    ..This pilot study assessed the feasibility of performing V/Q PET/CT and compared diagnostic utility with conventional V/Q imaging in patients with clinical suspicion of PE...
  5. pmc White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
    Michael S Hofman
    Center for Cancer Imaging, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, VIC 3002 Australia
    EJNMMI Res 1:2. 2011
    ..We discuss the potential biological basis of this finding and provide recommendations on the avoidance of this complication...
  6. doi request reprint The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable
    T W Barber
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia
    Eur J Surg Oncol 38:64-71. 2012
    ....